Top Markets
#1 MowCat MowCat +49.40%
#2 aPriori aPriori +32.37%
#3 Velvet Velvet +25.51%
#4 Bitway Bitway +21.02%
#5 OVERTAKE OVERTAKE +15.64%
#6 Derive Derive +15.56%
#7 Bermuda Shorts Bermuda Shorts +14.63%
#8 Merlin's Seal BTC Merlin's Seal BTC +13.49%
#9 Palladium Network Palladium Network +13.27%
#10 Perle Perle +13.07%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc.

GTTX
Rank in Stocks #34710
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in... GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
Share Price
$0.10409799
Last synced: 2025-02-03
Market Cap
$5.07M
Change (1 day)
16.43%
Change (1 year)
0.00%
Country
CA
Trade GeneTether Therapeutics Inc. (GTTX)

Category

Healthcare
EPS for GeneTether Therapeutics Inc. (GTTX)
EPS as of 2026 TTM: 0
According to GeneTether Therapeutics Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for GeneTether Therapeutics Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE